Senores Pharma secures Philippine FDA nod for 10 products, boosting SE Asia presence

• Senores Pharma secured Philippine FDA approval for 10 products.
• The approved products cover cardiovascular, CNS, and pain-management therapies.
• This approval is a key step in Senores Pharma's strategy to expand in Southeast Asia and provide affordable treatments.
• The approved products target a combined market size of $23 million in the Philippines.
• The company views the Philippines as a critical market for its regional expansion and aims to strengthen its position in Asia-Pacific.

Why It Matters: Senores Pharma expands market, offering affordable treatments in the Philippines.